Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction.
Bone marrow-mesenchymal stem cell (BM-MSC) therapy improves the recovery of cardiac function after myocardial infarction (MI); however, the underlying molecular mechanisms are not completely understood. Recent studies have shown that microRNAs (miRNAs) modulate the pathophysiology of cardiovascular...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5491110?pdf=render |
| _version_ | 1819243345715658752 |
|---|---|
| author | Yi-Sun Song Hyun-Woo Joo In-Hwa Park Guang-Yin Shen Yonggu Lee Jeong Hun Shin Hyuck Kim Kyung-Soo Kim |
| author_facet | Yi-Sun Song Hyun-Woo Joo In-Hwa Park Guang-Yin Shen Yonggu Lee Jeong Hun Shin Hyuck Kim Kyung-Soo Kim |
| author_sort | Yi-Sun Song |
| collection | DOAJ |
| description | Bone marrow-mesenchymal stem cell (BM-MSC) therapy improves the recovery of cardiac function after myocardial infarction (MI); however, the underlying molecular mechanisms are not completely understood. Recent studies have shown that microRNAs (miRNAs) modulate the pathophysiology of cardiovascular diseases. Here, we investigated the mechanisms underlying the effects of BM-MSC-derived paracrine factors and cardiac miRNAs on myocardial regeneration after MI. In our study, MI was induced by permanent ligation of the left anterior descending (LAD) coronary artery. BM-MSCs transplanted in infarcted rats significantly downregulated the expression of miRNA-23a and miRNA-92a and inhibited apoptosis in the myocardium. An in vitro experiment showed that supernatant from BM-MSCs cultured under hypoxia contained higher levels of vascular endothelial growth factor (VEGF) than that from BM-MSCs under normoxia. In addition, inhibition of miRNA-23a and miRNA-92a reduced cardiac apoptosis. Moreover, the VEGF-containing BM-MSC supernatant inhibited miRNA-23a and miRNA-92a expression and reduced apoptotic signaling in cardiomyocytes under hypoxia. These effects were inhibited when the supernatant was treated with neutralizing antibodies against VEGF. Our results indicate that the paracrine factor, VEGF, derived from transplanted BM-MSCs, regulated the expression of miRNAs such as miRNA-23a and miRNA-92a and exerted anti-apoptotic effects in cardiomyocytes after MI. |
| first_indexed | 2024-12-23T14:54:14Z |
| format | Article |
| id | doaj.art-81466bdb1f53411aadbab5e28c049019 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-23T14:54:14Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-81466bdb1f53411aadbab5e28c0490192022-12-21T17:42:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017997210.1371/journal.pone.0179972Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction.Yi-Sun SongHyun-Woo JooIn-Hwa ParkGuang-Yin ShenYonggu LeeJeong Hun ShinHyuck KimKyung-Soo KimBone marrow-mesenchymal stem cell (BM-MSC) therapy improves the recovery of cardiac function after myocardial infarction (MI); however, the underlying molecular mechanisms are not completely understood. Recent studies have shown that microRNAs (miRNAs) modulate the pathophysiology of cardiovascular diseases. Here, we investigated the mechanisms underlying the effects of BM-MSC-derived paracrine factors and cardiac miRNAs on myocardial regeneration after MI. In our study, MI was induced by permanent ligation of the left anterior descending (LAD) coronary artery. BM-MSCs transplanted in infarcted rats significantly downregulated the expression of miRNA-23a and miRNA-92a and inhibited apoptosis in the myocardium. An in vitro experiment showed that supernatant from BM-MSCs cultured under hypoxia contained higher levels of vascular endothelial growth factor (VEGF) than that from BM-MSCs under normoxia. In addition, inhibition of miRNA-23a and miRNA-92a reduced cardiac apoptosis. Moreover, the VEGF-containing BM-MSC supernatant inhibited miRNA-23a and miRNA-92a expression and reduced apoptotic signaling in cardiomyocytes under hypoxia. These effects were inhibited when the supernatant was treated with neutralizing antibodies against VEGF. Our results indicate that the paracrine factor, VEGF, derived from transplanted BM-MSCs, regulated the expression of miRNAs such as miRNA-23a and miRNA-92a and exerted anti-apoptotic effects in cardiomyocytes after MI.http://europepmc.org/articles/PMC5491110?pdf=render |
| spellingShingle | Yi-Sun Song Hyun-Woo Joo In-Hwa Park Guang-Yin Shen Yonggu Lee Jeong Hun Shin Hyuck Kim Kyung-Soo Kim Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction. PLoS ONE |
| title | Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction. |
| title_full | Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction. |
| title_fullStr | Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction. |
| title_full_unstemmed | Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction. |
| title_short | Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction. |
| title_sort | bone marrow mesenchymal stem cell derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac mirna 23a and mirna 92a in a rat model of myocardial infarction |
| url | http://europepmc.org/articles/PMC5491110?pdf=render |
| work_keys_str_mv | AT yisunsong bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction AT hyunwoojoo bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction AT inhwapark bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction AT guangyinshen bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction AT yonggulee bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction AT jeonghunshin bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction AT hyuckkim bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction AT kyungsookim bonemarrowmesenchymalstemcellderivedvascularendothelialgrowthfactorattenuatescardiacapoptosisviaregulationofcardiacmirna23aandmirna92ainaratmodelofmyocardialinfarction |